D. E. Shaw & Co., Inc. - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q4 2021$129,000
-84.8%
42,401
-66.3%
0.00%
-100.0%
Q3 2021$848,000
+208.4%
125,869
+609.4%
0.00%
Q2 2021$275,00017,7420.00%
Other shareholders
GT BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crumly & Associates Inc. 32,163$93,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 20,075$58,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 28,260$81,0000.00%
Sigma Planning Corp 21,400$62,0000.00%
Compagnie Lombard Odier SCmA 30,000$86,0000.00%
Gordian Capital Singapore Pte Ltd 35,000$3,0000.00%
Welch Group, LLC 10,000$29,0000.00%
Renaissance Technologies 186,300$537,0000.00%
BRIGHTON JONES LLC 11,012$32,0000.00%
Capital Advisors, Ltd. LLC 24$00.00%
View complete list of GT BIOPHARMA INC shareholders